Ben Hudson

1.3k total citations · 1 hit paper
20 papers, 862 citations indexed

About

Ben Hudson is a scholar working on Hepatology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ben Hudson has authored 20 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 12 papers in Epidemiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ben Hudson's work include Liver Disease and Transplantation (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (6 papers). Ben Hudson is often cited by papers focused on Liver Disease and Transplantation (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (6 papers). Ben Hudson collaborates with scholars based in United Kingdom and Australia. Ben Hudson's co-authors include William L. Irving, Kosh Agarwal, Michelle Cheung, Graham R. Foster, Alex J Walker, William Gelson, John McLauchlan, David Mutimer, Douglas MacDonald and Suman Verma and has published in prestigious journals such as The Lancet, Gut and Journal of Hepatology.

In The Last Decade

Ben Hudson

19 papers receiving 838 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

2016 328 citations Graham R. Foster, William L. Irving et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ben Hudson United Kingdom	11	760	703	85	74	35	20	862
James Galbraith United States	12	289 0.4×	366 0.5×	80 0.9×	29 0.4×	80 2.3×	25	520
Nickolas Kontorinis United States	11	353 0.5×	316 0.4×	31 0.4×	83 1.1×	108 3.1×	21	513
Mohammad Arif Saudi Arabia	12	388 0.5×	410 0.6×	23 0.3×	45 0.6×	131 3.7×	34	577
Vijaya Srinivasan India	10	145 0.2×	128 0.2×	32 0.4×	131 1.8×	31 0.9×	26	371
Naglaa Arafa Egypt	10	269 0.4×	247 0.4×	24 0.3×	15 0.2×	26 0.7×	18	397
Huaibin Zou China	10	692 0.9×	765 1.1×	18 0.2×	19 0.3×	187 5.3×	27	836
Premashish Kar India	11	255 0.3×	150 0.2×	21 0.2×	61 0.8×	73 2.1×	32	402
Heitor Rosa Brazil	10	258 0.3×	283 0.4×	13 0.2×	67 0.9×	63 1.8×	18	405
Yuan‐Jen Wang Taiwan	15	401 0.5×	327 0.5×	22 0.3×	58 0.8×	116 3.3×	36	571
Álvaro Mena Spain	12	337 0.4×	334 0.5×	13 0.2×	25 0.3×	241 6.9×	52	551

Countries citing papers authored by Ben Hudson

Since Specialization

Citations

This map shows the geographic impact of Ben Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Hudson more than expected).

Fields of papers citing papers by Ben Hudson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Hudson. The network helps show where Ben Hudson may publish in the future.

Co-authorship network of co-authors of Ben Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Hudson. A scholar is included among the top collaborators of Ben Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Hudson. Ben Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wright, Mark, Sumita Verma, Wendy Prentice, et al.. (2023). Developing a generic business case for an advanced chronic liver disease support service. Frontline Gastroenterology. 15(2). 104–109.

Macken, Lucia, Margaret Corrigan, Wendy Prentice, et al.. (2022). Palliative long-term abdominal drains for the management of refractory ascites due to cirrhosis: a consensus document. Frontline Gastroenterology. 13(e1). e116–e125. 13 indexed citations

Wright, Mark, et al.. (2022). Symptom control in advanced chronic liver disease: integrating anticipatory palliative and supportive care. Frontline Gastroenterology. 13(e1). e109–e115. 2 indexed citations

Dhanda, Ashwin, Victoria Allgar, Jackie Andrade, et al.. (2022). Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocol. BMJ Open. 12(5). e060498–e060498. 2 indexed citations

Hudson, Ben, et al.. (2019). Palliative care in liver disease: what does good look like?. Frontline Gastroenterology. 11(3). 218–227. 22 indexed citations

Hudson, Ben, Victoria Hunt, Andrea Waylen, et al.. (2018). The incompatibility of healthcare services and end-of-life needs in advanced liver disease: A qualitative interview study of patients and bereaved carers. Palliative Medicine. 32(5). 908–918. 40 indexed citations

Hudson, Ben, Jeff Round, Andrew Pring, et al.. (2017). Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England. The Lancet. Gastroenterology & hepatology. 3(2). 95–103. 35 indexed citations

Hudson, Ben, Alex J Walker, & William L. Irving. (2017). Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK. Journal of Medical Virology. 89(12). 2158–2164. 11 indexed citations

Cheung, Michelle, Alex J Walker, Ben Hudson, et al.. (2016). Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis. Journal of Hepatology. 65(4). 741–747. 285 indexed citations

10.

Foster, Graham R., William L. Irving, Michelle Cheung, et al.. (2016). Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis. Journal of Hepatology. 64(6). 1224–1231. 328 indexed citations breakdown →

11.

Cheung, Michelle, Graham R. Foster, William L. Irving, et al.. (2016). Antiviral Treatment in Patients with Advanced Hcv Cirrhosis Using Sofosbuvir and Ledipasvir/Daclatasvir with or without Ribavirin - 6 and 12 Month Outcomes Compared to Untreated Patients. Journal of Hepatology. 64(2). S185–S186. 7 indexed citations

12.

Cheung, Michelle, Graham R. Foster, William L. Irving, et al.. (2016). Antiviral treatment in patients with advanced hepatitis C virus cirrhosis with sofosbuvir and either ledipasvir or daclatasvir, with or without ribavirin: observational cohort study. The Lancet. 387. S26–S26. 2 indexed citations

13.

Hudson, Ben, Anya Göpfert, Karen Forbes, et al.. (2016). Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention. Frontline Gastroenterology. 8(1). 45–52. 32 indexed citations

14.

Hudson, Ben, et al.. (2015). PWE-091 Can screening for poor prognosis improve care for patients with end stage liver disease?. A252.1–A252. 1 indexed citations

15.

Foster, Graham R., John McLauchlan, William L. Irving, et al.. (2015). O002 : Treatment of decompensated HCV cirrhosis in patients with diverse genotypes: 12 weeks sofosbuvir and NS5A inhibitors with/without ribavirin is effective in HCV genotypes 1 and 3. Journal of Hepatology. 62. S190–S191. 48 indexed citations

16.

Hudson, Ben, et al.. (2011). Updated BSG guidelines for cancer surveillance in IBD – improving consensus and changing practice?. Gut. 60(Suppl 1). A203.2–A204. 3 indexed citations

17.

Arnold, Mark, et al.. (2009). Infectious Arthritis of the Knee Caused by Mycobacterium Terrae: A Case Report. Journal of orthopaedic surgery. 17(1). 103–108. 11 indexed citations

18.

Hudson, Ben & Colin Powell. (2008). QUESTION 1. Archives of Disease in Childhood. 94(2). 165–167. 3 indexed citations

19.

Khanna, Sanjay, Ben Hudson, Chris Pepper, Nazar N. Amso, & W.T. Coakley. (2006). Fluorescein isothiocynate-dextran uptake by chinese hamster ovary cells in a 1.5 mhz ultrasonic standing wave in the presence of contrast agent. Ultrasound in Medicine & Biology. 32(2). 289–295. 15 indexed citations

20.

Osborne, J. L., et al.. (1980). Effect of parental head circumference on that of the newborn child.. Archives of Disease in Childhood. 55(6). 480–482. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact